MedPath

四川德元药业集团有限公司

Ownership
-
Established
2001-02-19
Employees
-
Market Cap
-
Website
www.scdyyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

141

NMPA:141

Drug Approvals

夏桑菊颗粒

Approval Number
国药准字Z20093460
Approval Date
Jun 15, 2023
NMPA

德辉牌蜂胶软胶囊

Approval Number
国食健注G20090566
Approval Date
Jan 25, 2022
NMPA

金源牌越橘叶黄素软胶囊

Approval Number
国食健注G20210202
Approval Date
Dec 27, 2021
NMPA

德辉牌芦荟火麻仁胶囊

Approval Number
国食健注G20130266
Approval Date
Nov 11, 2021
NMPA

德辉牌螺旋藻洋参片

Approval Number
国食健注G20150572
Approval Date
Jul 23, 2021
NMPA

Cimetidine Tablets

Product Name
西咪替丁片
Approval Number
国药准字H51022944
Approval Date
May 14, 2021
NMPA

Levamisole Hydrochloride Tablets

Product Name
盐酸左旋咪唑片
Approval Number
国药准字H51023529
Approval Date
May 14, 2021
NMPA

Indometacin Enteric-coated Tablets

Product Name
吲哚美辛肠溶片
Approval Number
国药准字H51023531
Approval Date
May 14, 2021
NMPA

Vitamin　C　Tablets

Product Name
维生素C片
Approval Number
国药准字H51020989
Approval Date
May 14, 2021
NMPA

Isoniazid Tablets

Product Name
异烟肼片
Approval Number
国药准字H51022947
Approval Date
May 14, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 15
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.